Your browser is no longer supported. Please, upgrade your browser.
Assertio Holdings, Inc.
Index- P/E- EPS (ttm)-2.24 Insider Own0.90% Shs Outstand119.56M Perf Week9.48%
Market Cap57.91M Forward P/E5.36 EPS next Y0.11 Insider Trans-92.73% Shs Float102.85M Perf Month52.05%
Income-196.40M PEG- EPS next Q0.00 Inst Own44.60% Short Float1.20% Perf Quarter-17.19%
Sales135.30M P/S0.43 EPS this Y-634.30% Inst Trans-20.46% Short Ratio0.25 Perf Half Y-33.70%
Book/sh0.64 P/B0.92 EPS next Y-26.67% ROA-55.10% Target Price- Perf Year-51.23%
Cash/sh- P/C- EPS next 5Y25.00% ROE-259.40% 52W Range0.33 - 1.71 Perf YTD65.02%
Dividend- P/FCF- EPS past 5Y-28.50% ROI-39.80% 52W High-65.49% Beta1.69
Dividend %- Quick Ratio0.70 Sales past 5Y-10.10% Gross Margin88.40% 52W Low78.82% ATR0.06
Employees125 Current Ratio0.80 Sales Q/Q-37.20% Oper. Margin- RSI (14)62.34 Volatility12.46% 13.67%
OptionableYes Debt/Eq1.16 EPS Q/Q-292.20% Profit Margin- Rel Volume1.26 Prev Close0.63
ShortableYes LT Debt/Eq1.02 EarningsNov 06 BMO Payout- Avg Volume4.98M Price0.59
Recom2.50 SMA2030.84% SMA5033.41% SMA200-18.10% Volume6,276,075 Change-6.33%
Nov-30-18Downgrade Mizuho Buy → Neutral
Jan-15-21 04:27AM  
Jan-12-21 08:51AM  
Jan-11-21 07:30AM  
Jan-08-21 08:00AM  
Dec-29-20 04:05PM  
Dec-15-20 09:00AM  
Dec-12-20 11:35PM  
Dec-10-20 03:18AM  
Dec-09-20 07:30AM  
Dec-08-20 08:00AM  
Nov-19-20 08:00AM  
Nov-17-20 08:00AM  
Nov-10-20 04:01PM  
Nov-06-20 07:45AM  
Nov-04-20 09:47AM  
Oct-30-20 12:30PM  
Oct-27-20 06:30AM  
Oct-26-20 08:00AM  
Oct-24-20 05:30PM  
Oct-23-20 08:00AM  
Oct-20-20 07:30AM  
Oct-19-20 11:25AM  
Oct-14-20 10:17PM  
Oct-05-20 07:30AM  
Sep-15-20 08:00AM  
Sep-09-20 06:02AM  
Sep-08-20 12:13PM  
Sep-02-20 06:00AM  
Aug-25-20 12:16PM  
Aug-19-20 11:17AM  
Aug-18-20 08:59PM  
Aug-07-20 09:35AM  
Aug-06-20 03:50PM  
Jul-31-20 12:30PM  
Jul-28-20 04:30PM  
Jul-27-20 05:00PM  
Jul-24-20 12:01PM  
Jul-20-20 06:02AM  
Jul-16-20 04:45PM  
Jul-08-20 07:00AM  
Jun-30-20 11:50PM  
Jun-24-20 06:27PM  
May-22-20 07:24AM  
May-21-20 06:30AM  
May-20-20 06:20PM  
May-17-20 08:09AM  
May-11-20 10:35AM  
May-08-20 10:41PM  
May-06-20 12:30PM  
Apr-30-20 12:00PM  
Apr-20-20 05:08PM  
Apr-08-20 04:05PM  
Apr-02-20 06:24AM  
Mar-17-20 11:41AM  
Mar-16-20 06:45PM  
Mar-11-20 01:01AM  
Mar-09-20 05:55PM  
Mar-08-20 04:14PM  
Mar-02-20 05:30PM  
Feb-26-20 12:30PM  
Feb-24-20 10:33AM  
Feb-19-20 08:00AM  
Feb-17-20 06:00AM  
Feb-14-20 08:23AM  
Feb-13-20 04:05PM  
Feb-07-20 07:32AM  
Feb-06-20 04:01PM  
Feb-04-20 05:45PM  
Jan-29-20 05:45PM  
Jan-22-20 11:30AM  
Jan-15-20 05:45PM  
Jan-13-20 11:40AM  
Jan-09-20 05:45PM  
Jan-08-20 10:18AM  
Jan-07-20 09:51AM  
Dec-27-19 11:40AM  
Dec-23-19 12:00PM  
Assertio Holdings, Inc. operates as a specialty pharmaceutical company in the United States. Its specialty pharmaceutical products include CAMBIA, a non-steroidal anti-inflammatory drug (NSAID) for treating migraine; Zipsor, an NSAID for relief of mild to moderate acute pain; Gralise, a once-daily formulation of gabapentin for the management of postherpetic neuralgia; NUCYNTA ER, an extended-release version of tapentadol for the management of neuropathic pain associated with diabetic peripheral neuropathy; and NUCYNTA IR, an immediate release version of tapentadol for the management of moderate to severe acute pain. The company has a collaboration and license agreement with Ironwood Pharmaceuticals, Inc. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was founded in 1995 and is headquartered in Lake Forest, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CR Group L.P.10% OwnerDec 24Sale0.371,982,851730,086200,000Dec 29 09:15 PM
CR Group L.P.10% OwnerDec 23Sale0.376,784,3342,540,7332,182,851Dec 29 09:15 PM
CR Group L.P.10% OwnerDec 22Sale0.341,500,000508,5008,967,185Dec 22 09:31 PM
CR Group L.P.10% OwnerDec 21Sale0.36500,000180,10010,467,185Dec 22 09:31 PM
CR Group L.P.10% OwnerDec 18Sale0.38500,000188,80010,967,185Dec 22 09:31 PM
HIGGINS ARTHUR JDirectorDec 05Option Exercise0.0073,5290564,239Dec 07 04:51 PM
Peisert Daniel A.EVP and CFODec 01Option Exercise0.008,3580121,067Dec 02 04:59 PM
HIGGINS ARTHUR JDirectorDec 01Option Exercise0.0034,8600490,710Dec 02 04:58 PM
Wheadon David E.DirectorSep 28Option Exercise0.0048,3460285,846Sep 29 06:16 PM
Peisert Daniel A.EVP and CFOSep 18Option Exercise0.0011,6230116,114Sep 18 06:23 PM
Peisert Daniel A.EVP and CFOAug 15Option Exercise0.001,8140105,022Aug 17 07:08 PM
DAWES KAREN ADirectorMay 08Sale0.7915,83412,53184,589May 11 08:23 PM
Bukofzer StanSVP, Chf Scitfc & Tech OfficerApr 02Option Exercise0.0025,370070,349Apr 03 06:50 PM
Galeota James JRDirectorMar 30Option Exercise0.0012,492012,492Mar 31 07:32 PM
Mason Heather LDirectorFeb 18Option Exercise0.0014,394014,394Feb 19 05:00 PM
Peisert Daniel A.SVP and CFOFeb 12Option Exercise0.0027,5880112,753Feb 12 06:41 PM
Bukofzer StanSVP, Chf Scitfc & Tech OfficerFeb 12Option Exercise0.0027,588054,524Feb 12 06:40 PM
HIGGINS ARTHUR JDirector, President and CEOFeb 12Option Exercise0.0097,4120275,747Feb 12 06:41 PM
HIGGINS ARTHUR JDirector, President and CEOFeb 06Option Exercise0.0062,3990199,925Feb 06 05:49 PM
Peisert Daniel A.SVP and CFOFeb 06Option Exercise0.006,700087,483Feb 06 05:49 PM